New Silicone Gel-Filled Breast Implant Approved by FDA
2/22/2013
A new breast implant called the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size in females 22 and older and to rebuild breast tissue of women of all ages, has been approved by the US FDA. The Natrelle 410 implants are manufactured by Allergan, Inc...
An antidepressant drug used since the 1960s may also hold promise for treating sickle cell disease, according to a surprising new finding made in mice and human red blood cells by a team from the University of Michigan Medical School...
For Colorectal Cancer Prevention, Resistant Starch Should Be On The Menu
2/22/2013
As the name suggests, you can't digest resistant starch so it ends up in the bowel in pretty much the same form it entered your mouth. As unlovely as that seems, once in the bowel this resistant starch does some important things, including decreasing bowel pH and transit time, and increasing the production of short-chain fatty acids...
New Silicone Gel-Filled Breast Implant Approved by FDA
2/22/2013
A new breast implant called the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size in females 22 and older and to rebuild breast tissue of women of all ages, has been approved by the US FDA. The Natrelle 410 implants are manufactured by Allergan, Inc...
An antidepressant drug used since the 1960s may also hold promise for treating sickle cell disease, according to a surprising new finding made in mice and human red blood cells by a team from the University of Michigan Medical School...
BUSM Researchers Propose Potential Epigenetic Mechanisms For Improved Cancer Therapy
2/21/2013
A review article by researchers at Boston University School of Medicine (BUSM) proposes a new epigenetic hypothesis linked to tumor production and novel ideas about what causes progenitor cells to develop into cancer cells...
Regulating Differentiation Of Myeloid Cells In Cancer By Silencing Retinoblastoma Gene
2/21/2013
Researchers at the Moffitt Cancer Center have found a potential mechanism by which immune suppressive myeloid-derived suppressor cells can prevent immune response from developing in cancer. This mechanism includes silencing the tumor suppressor gene retinoblastoma 1 or Rb1. Their data explains a new regulatory mechanism by which myeloid-derived suppressor cells are expanded in cancer...
Imagine two steel springs identical in look and composition but that perform differently because each was tempered at a different rate. A team of researchers including a Texas A&M University molecular biologist has shown that concept - that the speed of creation affects performance - applies to how a protein they studied impacts an organism's circadian clock function...
Researchers Gain Insight Into Abnormally Shaped Cell Nuclei Of People With Cancer
2/21/2013
Misshapen cell nuclei are frequently observed in the cells of people with cancer and other diseases, but what causes the abnormality -- and why it is associated with certain disorders -- has remained unclear...
In High-Risk Patients, Head And Neck Cancer Could Be Prevented By New Drug Combination
2/21/2013
A new drug combination shows promise in reducing the risk for patients with advanced oral precancerous lesions to develop squamous cell carcinoma of the head and neck. The results of the study, which included preclinical and clinical analyses, were published in Clinical Cancer Research, a journal of the American Association for Cancer Research...